Combination of Selected MET and EGFR Inhibitors Decreases Melanoma Cells' Invasive Abilities.

导出 LinkOut

翻译打印收藏纠错

作者： Aleksandra,Simiczyjew ^[1] ; Katarzyna,Pietraszek-Gremplewicz ^[1] ; Ewelina,Dratkiewicz ^[1] ; Marta,Podgórska ^[1] ; Rafał,Matkowski ^[2] ; Marcin,Ziętek ^[3] ; Dorota,Nowak ^[2]

作者单位： Department of Cell Pathology, Faculty of Biotechnology, University of Wroclaw, Wroclaw, Poland. ^[1] Department of Oncology and Division of Surgical Oncology, Wroclaw Medical University, Wroclaw, Poland. ^[2] Lower Silesian Oncology Center, Wroclaw, Poland. ^[3]

关键词 EGFR MET foretinib gefitinib invadopodia invasion lapatinib melanoma

DOI 10.3389/fphar.2019.01116

PMID 31649529

发布时间 2020-09-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in pharmacology

2019年10卷

1116页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Combination of Selected MET and EGFR Inhibitors Decreases Melanoma Cells' Invasive Abilities.

Frontiers in pharmacology

相似文献

Frontiers in pharmacology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Combination of Selected MET and EGFR Inhibitors Decreases Melanoma Cells' Invasive Abilities.

Frontiers in pharmacology

相似文献

Frontiers in pharmacology

相关期刊

检索历史清除